Published in Diagn Microbiol Infect Dis on July 01, 2002
Investigative modalities in infectious keratitis. Indian J Ophthalmol (2008) 1.24
16S rRNA gene-based identification of bacteria in postoperative endophthalmitis by PCR-Denaturing Gradient Gel Electrophoresis (PCR-DGGE) fingerprinting. Braz J Microbiol (2012) 0.84
Phylogenetic analyses and detection of viridans streptococci based on sequences and denaturing gradient gel electrophoresis of the rod shape-determining protein gene. J Oral Microbiol (2009) 0.79
Non-culture-based analysis of bacterial populations from patients with chronic rhinosinusitis. J Clin Microbiol (2005) 0.78
Aurantimonas coralicida gen. nov., sp. nov., the causative agent of white plague type II on Caribbean scleractinian corals. Int J Syst Evol Microbiol (2003) 1.68
Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis. Clin Experiment Ophthalmol (2009) 1.44
Intraocular ointment after small-incision cataract surgery causing chronic uveitis and secondary glaucoma. J Cataract Refract Surg (2003) 1.44
Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res (2011) 1.35
A novel recombinant multisubunit vaccine against Chlamydia. J Immunol (2004) 1.34
Application of broad-range 16S rRNA PCR amplification and DGGE fingerprinting for detection of tick-infecting bacteria. J Microbiol Methods (2003) 1.21
Bacterial ghosts as vaccine candidates for veterinary applications. J Control Release (2002) 1.18
Microarray-based identification of bacteria in clinical samples by solid-phase PCR amplification of 23S ribosomal DNA sequences. J Clin Microbiol (2004) 1.16
Emended descriptions of the genus Micrococcus, Micrococcus luteus (Cohn 1872) and Micrococcus lylae (Kloos et al. 1974). Int J Syst Evol Microbiol (2002) 1.12
Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol (2008) 1.11
Linguatula serrata tongue worm in human eye, Austria. Emerg Infect Dis (2011) 1.10
Monitoring the colonization of monuments by bacteria: cultivation versus molecular methods. Environ Microbiol (2003) 1.04
Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge. Infect Immun (2005) 1.02
Influence of operator experience on the performance of ultrasound biometry compared to optical biometry before cataract surgery. J Cataract Refract Surg (2003) 1.01
Phylogenetic 16S rRNA analysis reveals the presence of complex and partly unknown bacterial communities in Tito Bustillo cave, Spain, and on its Palaeolithic paintings. Environ Microbiol (2002) 1.01
Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates. Infect Immun (2003) 1.01
The Bacterial Ghost platform system: production and applications. Bioeng Bugs (2011) 1.00
Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery. Expert Rev Vaccines (2003) 0.99
Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis. Vaccine (2003) 0.99
Phylogenetic diversity of bacteria associated with Paleolithic paintings and surrounding rock walls in two Spanish caves (Llonín and La Garma). FEMS Microbiol Ecol (2004) 0.99
Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine. J Microbiol Immunol Infect (2007) 0.99
Bacterial ghosts as adjuvant particles. Expert Rev Vaccines (2007) 0.98
Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits. Vaccine (2003) 0.96
Bacterial ghosts as antigen delivery vehicles. Adv Drug Deliv Rev (2005) 0.96
Agrococcus baldri sp. nov., isolated from the air in the 'Virgilkapelle' in Vienna. Int J Syst Evol Microbiol (2002) 0.95
Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors. Expert Rev Vaccines (2004) 0.95
Reading performance of patients with uveitis-associated cystoid macular edema. Am J Ophthalmol (2006) 0.95
Comparative immunogenicity of the hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts. Vaccine (2005) 0.95
Bacterial ghosts are an efficient delivery system for DNA vaccines. J Immunol (2004) 0.93
Uveal and capsular biocompatibility of 2 foldable acrylic intraocular lenses in patients with uveitis or pseudoexfoliation syndrome: comparison to a control group. J Cataract Refract Surg (2002) 0.92
Applications of bacterial ghosts in biomedicine. Adv Exp Med Biol (2009) 0.91
DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages. Mol Ther (2005) 0.87
Minicircle DNA immobilized in bacterial ghosts: in vivo production of safe non-viral DNA delivery vehicles. J Mol Microbiol Biotechnol (2004) 0.86
Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications. Expert Rev Vaccines (2012) 0.86
Bacillus barbaricus sp. nov., isolated from an experimental wall painting. Int J Syst Evol Microbiol (2003) 0.86
Uveitis and neurologic diseases: an often overlooked relationship. Wien Klin Wochenschr (2006) 0.86
Altamira cave Paleolithic paintings harbor partly unknown bacterial communities. FEMS Microbiol Lett (2002) 0.85
Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic cells. J Immunother (2005) 0.85
Bacterial ghosts--biological particles as delivery systems for antigens, nucleic acids and drugs. Curr Opin Biotechnol (2004) 0.85
Immobilization of plasmid DNA in bacterial ghosts. J Control Release (2005) 0.85
Comparison of ophthalmic sponges and extraction buffers for quantifying cytokine profiles in tears using Luminex technology. Mol Vis (2012) 0.85
Bacterial ghosts as novel advanced drug delivery systems: antiproliferative activity of loaded doxorubicin in human Caco-2 cells. J Control Release (2004) 0.84
Sealed bacterial ghosts--novel targeting vehicles for advanced drug delivery of water-soluble substances. J Drug Target (2003) 0.84
Modulation of gene expression by promoter mutants of the lambdacI857/pRM/pR system. J Biotechnol (2004) 0.84
Construction of recombinant S-layer proteins (rSbsA) and their expression in bacterial ghosts--a delivery system for the nontypeable Haemophilus influenzae antigen Omp26. FEMS Immunol Med Microbiol (2003) 0.84
Bacterial ghosts (BGs)--advanced antigen and drug delivery system. Vaccine (2010) 0.84
Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery. Expert Opin Drug Deliv (2006) 0.83
Bacterial Ghosts as antigen and drug delivery system for ocular surface diseases: Effective internalization of Bacterial Ghosts by human conjunctival epithelial cells. J Biotechnol (2011) 0.83
Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery. Am J Ophthalmol (2010) 0.82
In vitro and in vivo uptake study of Escherichia coli Nissle 1917 bacterial ghosts: cell-based delivery system to target ocular surface diseases. Invest Ophthalmol Vis Sci (2013) 0.82
Citricoccus muralis gen. nov., sp. nov., a novel actinobacterium isolated from a medieval wall painting. Int J Syst Evol Microbiol (2002) 0.82
Microbacterium aerolatum sp. nov., isolated from the air in the 'Virgilkapelle' in Vienna. Int J Syst Evol Microbiol (2002) 0.82
Understanding the impact of uveitis on health-related quality of life in adolescents. Acta Ophthalmol (2012) 0.81
Bacterial ghosts as a delivery system for zona pellucida-2 fertility control vaccines for brushtail possums (Trichosurus vulpecula). Vaccine (2008) 0.81
T cell-specific immune response induced by bacterial ghosts. Med Sci Monit (2004) 0.81
Effectiveness of engineering the nontypeable Haemophilus influenzae antigen Omp26 as an S-layer fusion in bacterial ghosts as a mucosal vaccine delivery. Hum Vaccin (2011) 0.80
Georgenia muralis gen. nov., sp. nov., a novel actinobacterium isolated from a medieval wall painting. Int J Syst Evol Microbiol (2002) 0.80
A three-centre experience with adalimumab for the treatment of non-infectious uveitis. Br J Ophthalmol (2012) 0.80
Proteomics and bioinformatics strategies to design countermeasures against infectious threat agents. J Chem Inf Model (2006) 0.80
Iron-regulated lysis of recombinant Escherichia coli in host releases protective antigen and confers biological containment. Infect Immun (2011) 0.80
Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge. Microb Biotechnol (2011) 0.79
Development of a Chlamydia trachomatis bacterial ghost vaccine to fight human blindness. Hum Vaccin (2010) 0.79
Detection of single nucleotide polymorphisms in coagulation factor XI deficient patients by multitemperature single-strand conformation polymorphism analysis. J Clin Lab Anal (2005) 0.79
Effective gene transfer to melanoma cells using bacterial ghosts. Cancer Lett (2007) 0.78
Identification of protein candidates for developing bacterial ghost vaccines against Brucella. Methods Biochem Anal (2006) 0.78
Delivery of Chlamydia vaccines. Expert Opin Drug Deliv (2005) 0.78
Fibroblast nemosis arrests growth and induces differentiation of human leukemia cells. Int J Cancer (2008) 0.77
Escherichia coli ghosts promote innate immune responses in human keratinocytes. Biochem Biophys Res Commun (2010) 0.77
Bacterial ghost technology for pesticide delivery. J Agric Food Chem (2004) 0.76
Implications for Ophthalmic Formulations: Ocular Buffers Show Varied Cytotoxic Impact on Human Corneal-Limbal and Human Conjunctival Epithelial Cells. Cornea (2017) 0.75
Modulation of bacterial ghosts--induced nitric oxide production in macrophages by bacterial ghost-delivered resveratrol. FEBS J (2013) 0.75
Promicromonospora vindobonensis sp. nov. and Promicromonospora aerolata sp. nov., isolated from the air in the medieval 'Virgilkapelle' in Vienna. Int J Syst Evol Microbiol (2003) 0.75
Screening for cystoid macular oedema in children with uveitis using the retinal thickness analyser. Acta Ophthalmol (2007) 0.75
Humoral immune responses in brushtail possums (Trichosurus vulpecula) induced by bacterial ghosts expressing possum zona pellucida 3 protein. Vaccine (2010) 0.75